Resolving Mass Tort Products Liability Claims

Devising Novel End-Game Strategies in Bet-the-Company Litigation

Wednesday, March 28, 2007

About

Make resolution part of your EARLY mass tort products liability strategy…

As plaintiffs use public opinion and the media to their advantage and file more high-risk and costly mass tort products liability claims, it is vital that you plan your end-game strategy early. Yet, you face major dilemmas. You believe in and have evidence of the safety of your product. Do you come to a reasonable settlement of claims to manage risk and defense costs or fully litigate and try these cases? Early settlement may be less costly in the overall context. But if you do not defend the product’s safety, are you encouraging plaintiffs to bring more claims?

Hear how to weigh your options carefully and master the nuts and bolts of implementing effective settlements

The American Conference Institute’s timely publication on Resolving Mass Tort Products Liability Claims was specifically designed to provide products liability litigators and in-house counsel the strategies and tools needed to devise novel end-game strategies to resolve “bet-the-company litigation.” The faculty of leading in-house litigation counsel, law firm attorneys, judges, dispute resolution experts, settlement administration firms, and communication/PR experts have been on the front lines of mass torts, and have defended nationwide litigation involving various products (drugs, implants, chemicals and many others).

Get the answers to the myriad questions involved in resolving mass claims

Contents & Contributors

About

Make resolution part of your EARLY mass tort products liability strategy…

As plaintiffs use public opinion and the media to their advantage and file more high-risk and costly mass tort products liability claims, it is vital that you plan your end-game strategy early. Yet, you face major dilemmas. You believe in and have evidence of the safety of your product. Do you come to a reasonable settlement of claims to manage risk and defense costs or fully litigate and try these cases? Early settlement may be less costly in the overall context. But if you do not defend the product’s safety, are you encouraging plaintiffs to bring more claims?

Hear how to weigh your options carefully and master the nuts and bolts of implementing effective settlements

The American Conference Institute’s timely publication on Resolving Mass Tort Products Liability Claims was specifically designed to provide products liability litigators and in-house counsel the strategies and tools needed to devise novel end-game strategies to resolve “bet-the-company litigation.” The faculty of leading in-house litigation counsel, law firm attorneys, judges, dispute resolution experts, settlement administration firms, and communication/PR experts have been on the front lines of mass torts, and have defended nationwide litigation involving various products (drugs, implants, chemicals and many others).

Get the answers to the myriad questions involved in resolving mass claims

Contents & Contributors

Developing Your Settlement Position With Respect to Mass Tort Product Claims
Orran L. Brown, BrownGreer PLC (Richmond, VA)
Ellen K. Reisman, Arnold & Porter LLP, (Los Angeles, CA)

The Settlement Endgame For Mass Torts
Richard A. Nagareda, Vanderbilt University Law School (Nashville, TN)

Establishing The Right Mix of Settlement Versus Litigation: Are Bellwether Trials Friends or Foes?
Robert E. Norton, DaimlerChrysler Corporation (Auburn Hills, MI)

Establishing the Right Mix of Settlement Versus Litigation: Are Bellwether Trials Friends or Foes?
Lana K. Varney, Fulbright & Jaworski LLP (Austin, TX)

Establishing the Right Mix of Settlement Versus Litigation: Are Bellwether Trials Friends or Foes?
Christian H. Gannon, Segal McCambridge Singer & Mahoney, Ltd. (New York, NY)

Meeting Objectives Through Defined Roles and Innovative Coordination Tactics Among Key Players
Jan E. Dodd, Kaye Scholer LLP (Los Angeles, CA)

Facilitating Cooperation and Coordination Among Co-Defense Counsel in Complex Toxic Tort Cases
Randolph T. Struk, Thorp Reed & Armstrong, LLP (Pittsburgh, PA)

Quantifying Total Damages to Come Up With Settlement Value
Douglas B. Schoettinger, DCC Litigation Facility Inc. (Midland, MI)
Dr. Faten Sabry, National Economic Research Associates, Inc. (New York, NY)
Robert E. Gifford, Steptoe & Johnson PLLC (Clarksburg, WV)

What You Must Know About Settlement Administration
Orran L. Brown, BrownGreer PLC (Richmond, VA)
James M. Doran Jr., Waller Lansden Dortch & Davis (Nashville, TN)

A Plaintiff's Perspective in Resolving Mass Tort Cases
Robert I. Komitor, Levy Phillips & Konigsberg, L.L.P. (New York, NY)

Confidentiality in Mass Tort Settlements
Hon. Ken M. Kawaichi (Ret.), The Resolution Experts (Walnut Creek, CA)

Nonconsenting Plaintiffs in Mass Settlements: Ethical Problems
John Leubsdorf, Rutgers School of Law (Newark, NJ)

Resolving Mass Tort Products Liability Claims: Bankruptcy Issues
Francis A. Citera, Greenberg Traurig, LLP (Chicago, IL)

Knock Knock, Regulators Calling
Beth Trent, Schering-Plough Corporation (Kenilworth, NJ)
Peter M. Kramer, Squire, Sanders & Dempsey L.L.P. (Miami, FL)
George A. Lehner, Pepper Hamilton LLP (Washington, DC)

Cooperative Defense Groups - Strategies for Cost Effective Collaboration
Edward Lowenberg, Exxon Mobil Corporation (Houston, TX)

Choosing Among ADR Options For Mass Torts
D. Alan Rudlin, Hunton & Williams LLP (Richmond, VA)



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0